Search Results 721-730 of 2364 for 谷歌日本搜索引入口咨询邮箱：lgooxc@hotmail.com
Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...
A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...
About this study. The purpose of this study is to examine if the addition of body weight support during ambulation on a treadmill and overground alters gait ...
About this study. To study intestinal permeability in participants with stage 3 colon cancer before and during chemotherapy and compare with controls with ...
The purpose of this study is to compare the performance (e.g., reliability), prognostic capacity, and clinical ease of use (e.g., memorability, scalability) of ...
About this study. The purpose of this study is to evaluate the effectiveness, safety, tolerability, PK, and pharmacodynamics of etigilimab in combination ...
The purpose of this study is to generate preliminary data on the impact of standard, first line treatment on the plasma metabolome of patients with a new ...
The purpose of this study is to analyze the effectiveness of antibiotics and closer monitoring on decreasing infection in patients discharging with a chest tube ...
About this study. The purpose of this study is to find out the effect of opening up a narrowed blood vessel supplying the lungs (pulmonary artery) on the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.